✦ LIBER ✦

537 POSTER Detection of EGFR mutation in the sample of pleural effusion is contributive as a determinant of EGFR-TKI-therapy for the patients with lung cancer

✍ Scribed by A. Uchida; T. Shibayama; S. Takahashi; N. Hamada; N. Kawata; A. Tada; R. Soda; K. Takahashi

Book ID: 119599693
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 55 KB
Volume: 6
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(08)72471-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of Tumor Specimens at the Time

Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers

✍ Yu, H. A.; Arcila, M. E.; Rekhtman, N.; Sima, C. S.; Zakowski, M. F.; Pao, W.; K 📂 Article 📅 2013 🏛 American Association for Cancer Research 🌐 English ⚖ 868 KB

PD-159 Mutation in the tyrosine kinase d

PD-159 Mutation in the tyrosine kinase domain of epidermal growthfactor receptor (EGFR) is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer (NSCLC)

✍ Tsai, C.; Chiu, C.; Chou, T.; Li, L.; Chang, K.; Chen, Y.; Tsai, S.; Perng, R. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 139 KB